Contact a Representative About TECENTRIQ

Receive TECENTRIQ information from your Genentech representative

Please remember: this feature is intended for US healthcare professionals only.

Please complete the form below if you would like a Genentech representative to contact you regarding your request to receive further information about TECENTRIQ (atezolizumab). You should receive a response within 2 business days.

Your contact information will only be used for a representative to respond to your information request. It will not be used for any other purpose unless you register for Genentech updates by checking the box below.

Personal information

*Indicates a required field.
Select
  • Clinical Coordinator
  • Clinical Nurse Specialist
  • Homecare Nurse
  • Nurse
  • Nurse Practitioner
  • Pharmacist
  • Physician
  • Physician Assistant
  • Resident/Fellow
  • Researcher
  • Other
Select
  • Medical Oncology
  • Pulmonary Critical Care Medicine
  • Pulmonary Disease
  • Radiation Oncology
  • Surgical Oncology
  • Other
Select
  • Dr
  • Mr
  • Mrs
  • Ms

My request is regarding (check all that apply)

By checking the box above, you agree to allow Genentech and its agents to collect the information provided and to be contacted by Genentech and its agents in the future regarding BioOncology products and related disease education.

By submitting this form, you agree to allow Genentech and its agents to collect the information provided and to be contacted directly by a Genentech representative. Your information will not be used for any other purpose than for a representative to respond to your information request, or for us to send you other Genentech BioOncology updates if you have registered to receive them.

Genentech will not sell, rent, or otherwise distribute your name and any personally identifiable information outside of Genentech and its agents. Genentech will only use your information in accordance with its Privacy Policy.

Thank you for registering for TECENTRIQ updates

Registration is complete.

We have received your request, and you are now registered to receive updates about TECENTRIQ (atezolizumab), TECENTRIQ.com, other Genentech BioOncology products, and related disease information.

The information you provided in this registration form will be used in accordance with Genentech Privacy Policy. Genentech will not sell, rent, or otherwise distribute your name and any personally identifiable information outside of Genentech and its agents. Also, any information or suggestions you provide regarding the content of any Genentech website, published document, or product will be handled in accordance with our Copyright Statement.

If you have any questions about the Genentech Privacy Policy or the information practices of our sites, you may contact us by email at privacy.office@gene.com or by mail at:

Genentech, Inc.
Attn: Privacy Office
1 DNA Way
South San Francisco, CA 94080